PTC Therapeutics, Inc. (PTCT) has a market capitalization of $6.04B and trades at $73.01. The 52-week range is 35.95-87.5.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of 8.5, Earnings Per Share (EPS) of $8.58, annual revenue of $1.73B.
The stock has a beta of 0.56, operates in the Healthcare sector.
